Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "TEDOVA Trial - Neo-Epitope Based Vaccine Alone or in Combination With Pembro vs. BSC as Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer With Disease Control After Platinum"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Alexandra Leary
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Alexandra Leary
Comments 0
Login to view comments.
Click here to Login
